InvestorsHub Logo
Followers 314
Posts 24877
Boards Moderated 9
Alias Born 10/26/2008

Re: None

Saturday, 06/05/2021 9:39:30 PM

Saturday, June 05, 2021 9:39:30 PM

Post# of 1582
ASCO Info...

Abstract Number: 2501
Abstract Title: Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.

Presenting Author: Julius Strauss, MD, National Cancer Institute
Session: Developmental Therapeutics—Immunotherapy
Date: June 7, 2021
Time: 3:00 PM-6:00 PM EDT

The abstract will be available on Wednesday, May 19 at 5:00 PM EDT on ASCO.org.


877-407-3088 is the number to listen in as frank reviews the Results on Tuesday 6/8 at 8:am

https://pdsbiotech.com/investors/news-center/press-releases/press-releases1/113-2021-news/516-iotechnnouncesralresentationof0101ataby20210429


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PDSB News